|

Integrated Motor-Cognitive Training in Parkinson's Disease: A Feasibility Study

RECRUITINGN/ASponsored by University Hospital of Ferrara
Actively Recruiting
PhaseN/A
SponsorUniversity Hospital of Ferrara
Started2026-06-01
Est. completion2026-08-31
Eligibility
Age18 Years+
Healthy vol.Accepted

Summary

Parkinson's disease is a progressive neurodegenerative condition characterized by both motor symptoms (such as bradykinesia, rigidity, tremor, and postural instability) and non-motor symptoms, including cognitive impairments (affecting working memory, executive functions, and attention). Combined interventions that target both domains simultaneously or consecutively have shown potential to produce superior benefits compared to isolated motor or cognitive training. The purpose of this study is to evaluate the feasibility, adherence, and preliminary clinical results of efficacy of an integrated and combined motor-cognitive rehabilitation training in patients diagnosed with Parkinson's disease. This feasibility study will enroll 12 participants with Parkinson's disease. All participants will undergo a comprehensive 10-session integrated rehabilitation program combining digital cognitive individual stimulation and group functional motor training. The primary focus is to assess acceptability, safety, and adherence to this combined approach, while secondary outcomes will observe changes in relevant cognitive and motor clinical variables.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Diagnosis of Parkinson's disease
* Presence of motor symptoms attributable to Parkinson's disease
* Availability to participate in both treatments (cognitive and motor)
* Severity of symptoms compatible with participation in group physical therapy
* Absence of other medical conditions that could interfere with treatment delivery
* Montreal Cognitive Assessment (MoCA) score \>= 18
* Consent to participate in group-based motor training
* Absence of falls in the 3 months prior to baseline evaluation

Exclusion Criteria:

* Concomitant major neurological or psychiatric disorders
* Severe cardio-pulmonary, renal, or hepatic diseases
* Changes in baseline pharmacological therapy within 3 months prior to enrollment

Conditions2

PARKINSON DISEASE (Disorder)Parkinson's Disease

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.